Previous 10 | Next 10 |
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, will host a virtual investor event on Wednesday, June 14, 2023 at 8:00 a.m. Eastern Time. Topics to be covered at the event include: Summary of new IMerge Phase 3 data in lower risk myelodysplastic syndro...
2023-06-05 06:00:00 ET 3 Tips to Develop a Risk Management Strategy for Trading Penny Stocks Trading penny stocks can offer an exciting avenue for investors seeking significant returns in a short period. As with any investment, a keen understanding of risk management is key to navigatin...
2023-06-04 11:00:00 ET 3 Things to Consider For Understanding Liquidity With Penny Stocks Penny stocks offer an intriguing opportunity for investors due to their low price and potential for substantial returns. However, understanding liquidity is vital to navigate the realm of penny s...
2023-05-31 10:45:37 ET FN Media Group Presents USA News Group News Commentary Vancouver, BC – May 31, 2023 – USA News Group – With this year’s Annual Meeting of the American Society of Clinical Oncology (ASCO 2023) less than 30 days ...
2023-05-31 09:47:21 ET Summary Geron Corporation's imetelstat has shown a clear benefit in treating lower-risk myelodysplastic syndromes (LR-MDS), with positive results in its phase 3 IMerge study. Imetelstat is likely to receive FDA approval for LR-MDS, with a potential priority ...
- Data support NDA submission which is on track for June 2023 to support potential U.S. commercial launch in first half of 2024 Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced acceptance of its IMerge Phase 3 abstract as an oral prese...
2023-05-24 13:33:04 ET In its preliminary annual 2023 Russell indexes reconstitution, a total of 164 companies will be added and 319 deleted from the Russell microcap index. Following notable healthcare companies will be added and deleted from Russell microcap index: Notable additio...
2023-05-15 06:00:00 ET 3 Top Tips for Analyzing Sectors to Find Penny Stocks Penny stocks, often priced under $5 per share, offer a unique opportunity for investors seeking high potential returns. These low-priced stocks are commonly found in emerging sectors, providing a golden chance ...
2023-05-14 11:32:00 ET 3 Myths About Trading Penny Stocks Debunked Penny stocks, characterized by their low market price typically under $5, have often been surrounded by a cloud of misconceptions. These misinterpretations, while pervasive, can be debunked with the right knowledge and u...
2023-05-11 18:30:54 ET Image source: The Motley Fool. Geron (NASDAQ: GERN) Q1 2023 Earnings Call May 11, 2023 , 10:30 a.m. ET Operator Continue reading For further details see: Geron (GERN) Q1 2023 Earnings Call Transcript
News, Short Squeeze, Breakout and More Instantly...
RYTELO, for both RS+ and RS- patients, has a Category 1 recommendation for second-line treatment and a Category 2A recommendation for first-line treatment of patients who are ESA ineligible (serum EPO >500 mU/mL) Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical ...
Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that Anil Kapur, Executive Vice President, Corporate Strategy and Chief Commercial Officer, will depart the Company on August 31, 2024, to ...
Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced that it will release its second quarter 2024 financial results and business highlights before the market opens on Thursday, August 8, 2024 via press release, which will be available on the Company ...